{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 140,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "import requests\n",
    "from bs4 import BeautifulSoup\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "import time\n",
    "import json\n",
    "from collections import namedtuple\n",
    "import csv"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 143,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "def cleaner(r, u):\n",
    "    try:\n",
    "        c = r[0].p.get_text(strip=True)\n",
    "    except:\n",
    "        c = ''\n",
    "    try:\n",
    "        d = r[3].img['src']\n",
    "    except:\n",
    "        d = ''\n",
    "    return  [u+r[0].a['href'], r[0].a.get_text(strip=True), c, r[1].get_text(strip=True), r[2].get_text(strip=True), d]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 171,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "classes = ['company-description', 'company-contact', 'company-info']\n",
    "\n",
    "def cleaner_(r):\n",
    "    vals = [l.a['href'] for l in r[1].find_all('li', class_ = 'actions')]\n",
    "    a = [v.split(':')[1] if v[0] in ['c', 'm']  else v for v in vals]\n",
    "    b = r[0].get_text(strip=True)\n",
    "    c = '\\n'.join([d.get_text() for d in r[1].address.find_all('div')][1:])\n",
    "    r2 = r[2].find_all('div', recursive = False)\n",
    "    vals_ = [a_ for a_ in r2[1].find_all('li')]\n",
    "    e = []\n",
    "    f = (r2[0].h5.get_text(), r2[0].find(property = 'name').get_text())\n",
    "    for v_ in vals_:\n",
    "        v = unicode(v_.h5.text)\n",
    "        v_.h5.clear()\n",
    "        e.append((v, \" \".join(v_.get_text(strip=True).split())))\n",
    "    try:\n",
    "        r2[2]\n",
    "    except IndexError:\n",
    "        d = []\n",
    "    else:\n",
    "        d = [(a_.get_text(), a_.a['href']) for a_ in r2[2].find_all(class_ = 'file')]\n",
    "    return [f]+[b]+a+[c]+e+d"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 174,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "http://www.swedishlifesciences.se/company-index?title=&page=0\n",
      "http://www.swedishlifesciences.se/company-index?title=&page=1\n",
      "http://www.swedishlifesciences.se/company-index?title=&page=2\n",
      "http://www.swedishlifesciences.se/company-index?title=&page=3\n",
      "http://www.swedishlifesciences.se/company-index?title=&page=4\n",
      "http://www.swedishlifesciences.se/company-index?title=&page=5\n",
      "http://www.swedishlifesciences.se/company-index?title=&page=6\n",
      "http://www.swedishlifesciences.se/company-index?title=&page=7\n",
      "http://www.swedishlifesciences.se/company-index?title=&page=8\n",
      "http://www.swedishlifesciences.se/company-index?title=&page=9\n",
      "http://www.swedishlifesciences.se/company-index?title=&page=10\n",
      "http://www.swedishlifesciences.se/company-index?title=&page=11\n",
      "http://www.swedishlifesciences.se/company-index?title=&page=12\n",
      "http://www.swedishlifesciences.se/company-index?title=&page=13\n",
      "http://www.swedishlifesciences.se/company-index?title=&page=14\n",
      "http://www.swedishlifesciences.se/company-index?title=&page=15\n",
      "http://www.swedishlifesciences.se/company-index?title=&page=16\n"
     ]
    }
   ],
   "source": [
    "companies = []\n",
    "for p in range(0, 17):\n",
    "    url = 'http://www.swedishlifesciences.se'\n",
    "    ext = \"/company-index?title=&page=\"+str(int(p))\n",
    "    print url+ext\n",
    "    soup = BeautifulSoup(requests.get(url+ext).text, \"html.parser\")\n",
    "    data = soup.table\n",
    "    companies = companies+[cleaner(rows.find_all('td'), url) for rows in data.find_all('tr', class_ = \"company premium\")]\n",
    "    time.sleep(1)    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 177,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "53\n",
      "0\n",
      "10\n",
      "http://www.swedishlifesciences.se/aurena-laboratories-ab\n",
      "20\n",
      "http://www.swedishlifesciences.se/kuehne-nagel-ab\n",
      "30\n",
      "http://www.swedishlifesciences.se/mia-ostlund-consulting\n",
      "40\n",
      "50\n"
     ]
    }
   ],
   "source": [
    "companies_full = []\n",
    "print len(companies)\n",
    "for i, c in enumerate(companies):\n",
    "    try:\n",
    "        if not i % 10:\n",
    "            print i\n",
    "        url = c[0]\n",
    "        soup = BeautifulSoup(requests.get(url).text, \"html.parser\")\n",
    "        data = soup.find(class_  = 'main-content')\n",
    "        if len(data.find_all('div')) == 3:\n",
    "            companies_full.append(c+[data.find_all('div')[2].a['href']])\n",
    "        else:\n",
    "            companies_full.append(c+['']+cleaner_(data.find_all(class_ = classes)))\n",
    "            #data.find_all(class_ = classes)[2].find_all('div', recursive = False)[0].h5\n",
    "        time.sleep(1)\n",
    "    except:\n",
    "        print c[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 178,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[[u'http://www.swedishlifesciences.se/a-science-ab',\n",
       "  u'A+ Science AB',\n",
       "  u'To Earn Trust - Make Difference',\n",
       "  u'Stockholm',\n",
       "  u'CROs',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/722/logo/188_logo_high.jpg?itok=e3dsUxdR',\n",
       "  '',\n",
       "  (u'CEO', u'Anna Fr\\xf6ling'),\n",
       "  u'A+ Science is a Contract Research Organization (CRO) with long experience of services in clinical trials for pharmaceuticals (Phase I-IV), medical devices as well as non-interventional and registry trials. \\r\\n\\r\\nOur core expertise is in the Nordic countries, however through our close collaboration with other CROs, we are also able to cover many other countries. Our services include Clinical Trial Management, Pharmacovigilance (Pre-and Post-Marketing), Outsourcing of Consultants (short and long term solutions), City Site (Site Management Organization), Continuing Medical Education, Regulatory Services and many others. \\r\\n\\r\\nSince December 2013, A+ Science is a CRO run by its employees.',\n",
       "  u'08-564 882 30',\n",
       "  u'http://www.a-plusscience.com',\n",
       "  u'tania.persson@a-plusscience.com',\n",
       "  u'https://www.facebook.com/#!/groups/222121887912067/',\n",
       "  u'Luntmakargatan 22\\n11137 Stockholm',\n",
       "  (u'Category', u'Contract Research Organisations'),\n",
       "  (u'Founded', u'1997'),\n",
       "  (u'Public company', u'Yes'),\n",
       "  (u'Revenue', u'26 MSEK in Sweden'),\n",
       "  (u'Number of employees', u'25'),\n",
       "  (u'Chairman', u'H\\xe5kan Gartell'),\n",
       "  (u' city_site_presentation_2014.pdf',\n",
       "   u'http://www.swedishlifesciences.se/sites/default/files/city_site_presentation_2014.pdf'),\n",
       "  (u' company_presentation_ascience_2015.pdf',\n",
       "   u'http://www.swedishlifesciences.se/sites/default/files/company_presentation_ascience_2015.pdf')],\n",
       " [u'http://www.swedishlifesciences.se/ab-carlsson-och-moller',\n",
       "  u'AB Carlsson och M\\xf6ller',\n",
       "  '',\n",
       "  u'Helsingborg',\n",
       "  u'Medtech',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1197/logo/c_m_logo.jpg?itok=SAjlenM3',\n",
       "  '',\n",
       "  (u'CEO', u'Michael Andersson'),\n",
       "  u'Carlsson & M\\xf6ller, founded in 1948, is one of the leading companies in engineering plastics. The business comprises three main areas: Wholesaling, Mechanical processing of components and Materials and Application expertise.\\r\\n\\r\\nC & M MedTech is a department within the company focused on engineering plastics for medical applications. \\r\\nC & M MedTech has extensive experience in engineering plastics in medical and biotechnical applications and offers specialist technical support and advisory services - from concept development and material selection, to prototyping and serial production.\\r\\n\\r\\nCarlsson & M\\xf6ller is part of Indutrade AB - a group with 170 companies in 25 countries and 4000 employees.',\n",
       "  u'042-253800',\n",
       "  u'http://www.c-m.se/',\n",
       "  u'Garnisonsgatan 45\\n25023 Helsingborg',\n",
       "  (u'Category', u'Medtech'),\n",
       "  (u'Founded', u'1948'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Revenue', u'90 MSEK in Sweden'),\n",
       "  (u'Number of employees', u'61'),\n",
       "  (u'Chairman', u'G\\xf6te Mattson'),\n",
       "  (u'Principal owners', u'Indutrade AB'),\n",
       "  (u' folder_cm_medtech.pdf',\n",
       "   u'http://www.swedishlifesciences.se/sites/default/files/folder_cm_medtech_0.pdf')],\n",
       " [u'http://www.swedishlifesciences.se/abigo-medical-ab',\n",
       "  u'Abigo Medical AB',\n",
       "  u'Fast-growing Swedish pharmaceutical company',\n",
       "  u'Askim',\n",
       "  u'Pharma',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/604/logo/abigojpg.jpg?itok=16dabGe4',\n",
       "  '',\n",
       "  (u'CEO', u'Jan G. Smith'),\n",
       "  u'ABIGO Medical AB is a globally expanding, integrated pharmaceutical company fully owned by the two brothers Jan. G and Leif Smith. A focus area and a research priority for ABIGO is infection control. In addition to the pharmaceutical products, ABIGO Medical has an advanced wound care product line. The Sorbact\\xae-method is a unique Swedish invention for the effective management of wounds and dermal fungal infections. The Sorbact\\xae wound management product line offers effective wound healing, including the prevention and management of infections. In addition, no known side effects or risk of microorganism resistance development has ever been demonstrated, a truly unique combination. Sorbact\\xae is successfully sold in 65 countries.',\n",
       "  u'031-7484950',\n",
       "  u'http://www.abigo.com',\n",
       "  u'Jan.g.smith@abigo.se',\n",
       "  u'Ekonomiv\\xe4gen 5\\n43633 Askim',\n",
       "  (u'Category', u'Pharma'),\n",
       "  (u'Founded', u'1989'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Number of employees', u'115'),\n",
       "  (u'Chairman', u'Jan G. Smith'),\n",
       "  (u'Principal owners', u'Jan G. Smith, Leif Smith')],\n",
       " [u'http://www.swedishlifesciences.se/acreo-swedish-ict-ab',\n",
       "  u'Acreo Swedish ICT AB',\n",
       "  u'Innovation for Sustainable Growth',\n",
       "  u'Kista',\n",
       "  u'Biotech',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/606/logo/ict_acreo_logo_web.jpg?itok=wcfbo0Qw',\n",
       "  '',\n",
       "  (u'Business Unit Director', u'Sara Bogren'),\n",
       "  u'Acreo Swedish ICT offers a Multi-disciplinary Innovation environment to take Life Science research concepts to manufacturable prototypes. Our Life Science focus is upon diagnostics and detection, research tools and eHealth-solutions. As your R&D-partner - we can assist in any stage of bringing new ideas to the market. We have the technology competence, we have the laboratories and test environments, we know prototyping, licensing and patents. And we have strong national and international networks \\u2013 academic as well as business network. Acreo is part of Swedish ICT and RISE.',\n",
       "  u'+46 (0)10 522 00 30',\n",
       "  u'http://www.acreo.se',\n",
       "  u'info@acreo.se',\n",
       "  u'https://www.facebook.com/acreoswedishict',\n",
       "  u'https://twitter.com/AcreoSwedishICT',\n",
       "  u'Box 1070\\nIsafjordsgatan 22\\n164 25 Kista',\n",
       "  (u'Category', u'Biotech'),\n",
       "  (u'Looking for capital', u'Yes'),\n",
       "  (u'Founded', u'1999'),\n",
       "  (u'Public company', u'Yes'),\n",
       "  (u'Revenue', u'187 MSEK in Sweden'),\n",
       "  (u'Number of employees', u'137'),\n",
       "  (u'Chairman', u'Hans Hentzell'),\n",
       "  (u'Principal owners', u'Swedish ICT Research AB')],\n",
       " [u'http://www.swedishlifesciences.se/active-biotech-ab',\n",
       "  u'Active Biotech AB',\n",
       "  u'Development of pharmaceuticals',\n",
       "  u'Lund',\n",
       "  u'Biotech',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/607/logo/active_biotech_ab-logo_low.jpg?itok=bPTEyPp2',\n",
       "  '',\n",
       "  (u'CEO', u'Tomas Leanderson'),\n",
       "  u'Active Biotech AB (publ) (Nasdaq Stockholm: ACTI) is a biotechnology company with focus on neurodegenerative diseases and cancer. Projects in pivotal phase are laquinimod, an orally administered small molecule with unique immunomodulatory properties for the treatment of multiple sclerosis, and tasquinimod, an oral immunomodulatory, anti-metastatic substance for the treatment of prostate cancer. The objective of the preclinical ISI project is to produce new, patentable chemical compounds for treatment of diseases in the company\\u2019s focus areas. Please visit www.activebiotech.com for more information.',\n",
       "  u'046-192000',\n",
       "  u'http://www.activebiotech.com',\n",
       "  u'cecilia.hofvander@activebiotech.com',\n",
       "  u'P.O. Box 724\\nScheelev\\xe4gen 22\\n22007 Lund',\n",
       "  (u'Category', u'Biotech'),\n",
       "  (u'Founded', u'1997'),\n",
       "  (u'Public company', u'Yes'),\n",
       "  (u'Revenue', u'10.4 MSEK in Sweden'),\n",
       "  (u'Number of employees', u'56'),\n",
       "  (u'Chairman', u'Mats Arnh\\xf6g'),\n",
       "  (u'Principal owners', u'MGA Holding AB, Nordstjernan AB, Investor')],\n",
       " [u'http://www.swedishlifesciences.se/adlego-biomedical-ab',\n",
       "  u'Adlego Biomedical AB',\n",
       "  u'A small enterprice with large capacities',\n",
       "  u'Uppsala',\n",
       "  u'CROs',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1191/logo/4621_logo_high.jpg?itok=4H0crcX7',\n",
       "  '',\n",
       "  (u'CEO', u'Urban H\\xf6glund'),\n",
       "  u'We are a team of professionals with long time experience of in-vivo pharmacology and toxicology. We assist pharmaceutical companies in their endeavours to find cures for diseases for which there are no effective treatments today and those who are working to improve the effectiveness of discovered drugs. Although we perform the standard studies needed to document the effect of new drug candidates we are always intersted in adding new effect models to our portfolio. In the development of effect models our extensive experience in pharmacology and physiology is fully utilized.',\n",
       "  u'073-3421737',\n",
       "  u'http://www.adlego.se',\n",
       "  u'urban.hoglund@adlego.se',\n",
       "  u'Box 42\\n75103 Uppsala',\n",
       "  (u'Category', u'Contract Research Organisations'),\n",
       "  (u'Founded', u'2005'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Principal owners', u'Urban H\\xf6glund')],\n",
       " [u'http://www.swedishlifesciences.se/advokatfirman-glimstedt',\n",
       "  u'Advokatfirman Glimstedt',\n",
       "  u'Legal service for Life Science companies',\n",
       "  u'Lund',\n",
       "  u'Intellectual Property',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1205/logo/logo_rgb_ny.jpg?itok=_ZSedlDM',\n",
       "  '',\n",
       "  (u'Business Unit Director', u'Jens Kinnander'),\n",
       "  u'Glimstedt is a full-service law firm with a unique geographic spread. In all, we have a staff of 260 at our offices in Sweden, Estonia, Latvia, Lithuania and Belarus. Around 200 of us are lawyers. Within Life Sciences, we advise and assist in drafting and negotiating agreements regarding e.g. license agreements, research and development agreements, manufacturing and supply agreements, agreements regarding clinical studies and other agreements for the day-to-day business, as well as acquiring and divesting business lines. Glimstedt assists start-ups as well as established companies within the fields of biotechnology, medical technology and the food industry.',\n",
       "  u'046-12 40 30',\n",
       "  u'http://www.glimstedt.se',\n",
       "  u'jens.kinnander@glimstedt.se',\n",
       "  u'Box 1246\\nByggm\\xe4staregatan 5\\n221 05 Lund',\n",
       "  (u'Category', u'Intellectual Property'),\n",
       "  (u'Founded', u'1923'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Number of employees', u'260'),\n",
       "  (u'Chairman', u'Bo Ahlenius')],\n",
       " [u'http://www.swedishlifesciences.se/alteco-medical-ab',\n",
       "  u'Alteco Medical AB',\n",
       "  u'Sepsis (livshotande blodf\\xf6rgiftning)',\n",
       "  u'Lund',\n",
       "  u'Medtech',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1282/logo/alteco_medical_logo_rgb.png?itok=RgJugZ9V',\n",
       "  '',\n",
       "  (u'CEO', u'Jonas J\\xf6nmark'),\n",
       "  u'Sepsis \\xe4r en av de vanligaste d\\xf6dsorsakerna inom den moderna intensivv\\xe5rden. Antalet patienter med sepsis har \\xf6kat med omkring 100 procent det senaste \\xe5rtiondet. Vidare \\xe4r sepsis den fr\\xe4msta d\\xf6dsorsaken i samband med allvarliga infektioner, trots stora medicinska framsteg inom vaccinationer, antibiotika och avancerad intensivv\\xe5rd. Fler m\\xe4nniskor avlider \\xe5rligen av sepsis \\xe4n av HIV, lung-, br\\xf6st- och prostatacancer tillsammans och det finns ett mycket stort behov inom intensivv\\xe5rden av nya behandlingsmetoder f\\xf6r att f\\xf6rb\\xe4ttra \\xf6verlevnaden bland patienter med sepsis. Alteco s\\xe4ljer den patenterade CE-m\\xe4rkta Alteco\\xae LPS Adsorber som anv\\xe4nds till att behandla sepsis.',\n",
       "  u'http://www.altecomedical.com',\n",
       "  u'info@altecomedical.com',\n",
       "  u'H\\xf6stbruksv\\xe4gen 8\\n22660 Lund',\n",
       "  (u'Category', u'Medtech'),\n",
       "  (u'Public company', u'Yes'),\n",
       "  (u'Number of employees', u'7'),\n",
       "  (u'Chairman', u'Hans Petersson'),\n",
       "  (u'Principal owners', u'Anders Althin')],\n",
       " [u'http://www.swedishlifesciences.se/anamar-ab',\n",
       "  u'AnaMar AB',\n",
       "  u'With focus on inflammation and fibrosis',\n",
       "  u'G\\xf6teborg',\n",
       "  u'Biotech',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/622/logo/logo-anamar-400.jpg?itok=b03zaaiA',\n",
       "  '',\n",
       "  (u'CEO', u'Owe G\\xe5rlin'),\n",
       "  u'AnaMar is a  biopharmaceutical company deploying a selective peripheral serotonin (5-hydroxytryptamine or 5-HT) receptor platform to build a pipeline of clinical-stage drug development candidates targeting severe inflammatory and fibrotic diseases associated with high levels of morbidity and mortality. We address huge unmet medical needs as well as great market potentials. AnaMar has a unique technological platform with several drug candidates in development. We are a competent and dependable potential partner with sustainable financial backing. The Company is actively seeking and currently evaluating potential partnerships to help leverage and maximize its platform and accelerate development and commercialization of its pipeline.',\n",
       "  u'031-7324140',\n",
       "  u'http://www.anamar.com',\n",
       "  u'info@anamar.com',\n",
       "  u'Kungsportsavenyn 22\\n41136 G\\xf6teborg',\n",
       "  (u'Category', u'Biotech'),\n",
       "  (u'Founded', u'1998'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Revenue', u'1 MSEK Worldwide'),\n",
       "  (u'Number of employees', u'14'),\n",
       "  (u'Chairman', u'Staffan Encrantz'),\n",
       "  (u'Principal owners', u'Koncentra Holding AB')],\n",
       " [u'http://www.swedishlifesciences.se/apl-apotek-produktion-laboratorier-ab',\n",
       "  u'APL - Apotek Produktion & Laboratorier AB',\n",
       "  u'Development and manufacturing services',\n",
       "  u'Kungens Kurva, Stockholm',\n",
       "  u'CMOs',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/882/logo/514_logo_high.png?itok=JUnhERQp',\n",
       "  '',\n",
       "  (u'CEO', u'Eva Sj\\xf6kvist Saers'),\n",
       "  u'APL offers laboratory, development and manufacturing services from single testing of active compounds to commercial manufacturing. With APL as a partner you receive a seamless process from early clinical phases through scale-up to full scale manufacturing. With a custom oriented approach and a transparent workflow we service all type of companies, from the small start-up to the global big pharma. We work with all common dosage forms and meet the quality requirements for global markets. Our expertise is based on more than 30 years experience in manufacturing pharmaceutical.',\n",
       "  u'010-447 96 00',\n",
       "  u'http://www.apl.se',\n",
       "  u'Eva.SjokvistSaers@apl.se',\n",
       "  u'Box 5071\\nPrismav\\xe4gen 2\\n14175 Kungens Kurva, Stockholm',\n",
       "  (u'Category', u'Contract Manufacturing Organisations'),\n",
       "  (u'Founded', u'1971'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Revenue', u'1 200 MSEK Worldwide'),\n",
       "  (u'Number of employees', u'550'),\n",
       "  (u'Chairman', u'Johan Assarsson'),\n",
       "  (u'Principal owners', u'Swedish Government'),\n",
       "  (u' Business Area Life science booklet',\n",
       "   u'http://www.swedishlifesciences.se/sites/default/files/apl_life_science_booklet.pdf'),\n",
       "  (u' Annual Report 2014',\n",
       "   u'http://www.swedishlifesciences.se/sites/default/files/apl_annual_report_2014.pdf')],\n",
       " [u'http://www.swedishlifesciences.se/assuransselector-ab',\n",
       "  u'AssuransSelector AB',\n",
       "  u'Insurance Services',\n",
       "  u'Helsingborg',\n",
       "  u'Service',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/833/logo/assuransselector_ab-logo_low.jpg?itok=W0nn8K26',\n",
       "  '',\n",
       "  (u'CEO', u'Sigvard \\xc5kerman'),\n",
       "  u'AssuransSelector AB offers tailored, cost-effective insurance cover for the Life Science industry, such as:-Product Liability Insurance-Recall Insurance-Clinical Trials Insurance-Intellectual Property Rights Insurance-Directors & Officers Liability InsuranceWhether our client is in an early stage of development or is already a large manufacturer, we understand the risks and provide help in protecting the company against them.',\n",
       "  u'042-120760',\n",
       "  u'http://www.assuransselector.se',\n",
       "  u'lifescience@assuransselector.se',\n",
       "  u'Drottninggatan 11\\n25221 Helsingborg',\n",
       "  (u'Category', u'Service'),\n",
       "  (u'Founded', u'1987'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Revenue', u'7 MSEK in Sweden'),\n",
       "  (u'Number of employees', u'4'),\n",
       "  (u'Chairman', u'Mats Johnsson'),\n",
       "  (u'Principal owners', u'AssuransSelector Holding AB')],\n",
       " [u'http://www.swedishlifesciences.se/astrazeneca-ab',\n",
       "  u'AstraZeneca AB',\n",
       "  u'World leading in healthcare',\n",
       "  u'S\\xf6dert\\xe4lje',\n",
       "  u'Pharma',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/629/logo/az_cmyk_h_col.jpg?itok=I3t4qj8m',\n",
       "  '',\n",
       "  (u'CEO', u'Pascal Soriot'),\n",
       "  u'AstraZeneca \\xe4r ett globalt, innovativt biol\\xe4kemedelsf\\xf6retag med fokus p\\xe5 forskning, utveckling och marknadsf\\xf6ring av receptbelagda l\\xe4kemedel, prim\\xe4rt f\\xf6r behandling av sjukdomar inom omr\\xe5dena hj\\xe4rta/k\\xe4rl/metabolism, andningsv\\xe4gar/inflammation/autoimmunitet, cancer, infektion och neurovetenskap. AstraZeneca \\xe4r verksamt i \\xf6ver 100 l\\xe4nder och v\\xe5ra innovativa l\\xe4kemedel anv\\xe4nds av miljontals patienter v\\xe4rlden \\xf6ver.',\n",
       "  u'08-55326000',\n",
       "  u'http://www.astrazeneca.se',\n",
       "  u'kontakt@astrazeneca.com',\n",
       "  u'https://twitter.com/AstraZenecaSE',\n",
       "  u'Astraall\\xe9n\\n15185 S\\xf6dert\\xe4lje',\n",
       "  (u'Category', u'Pharma'),\n",
       "  (u'Founded', u'1999'),\n",
       "  (u'Public company', u'Yes'),\n",
       "  (u'Revenue', u'26 095 MUSD Worldwide'),\n",
       "  (u'Number of employees', u'57 500'),\n",
       "  (u'Chairman', u'Leif Johansson'),\n",
       "  (u'Principal owners',\n",
       "   u'BlackRock. Inc, Invesco Limited, Axa SA, Investor AB')],\n",
       " [u'http://www.swedishlifesciences.se/belach-bioteknik-ab',\n",
       "  u'Belach Bioteknik AB',\n",
       "  u'Customized bioprocess systems since 1985',\n",
       "  u'Skog\\xe5s',\n",
       "  u'Suppliers (Manufactures)',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/636/logo/51_logo_high.jpg?itok=jjI3HBx_',\n",
       "  '',\n",
       "  (u'CEO', u'Gy\\xf6rgy Rajkai'),\n",
       "  u'Belach is a company with 30 years experience in the field of bioprocess technology. Founding members established Belach Bioteknik AB in 1985 with the intention to supply the market with high quality fermentation equipment. Since then we have designed and manufactured qualified computer controlled bioreactor systems for cell and microbial cultivations used in research and production in most Swedish biopharmaceutical companies and research institutes. Over the years, Belach Bioteknik AB has become acknowledged on the Scandinavian biotech market for flexible services and long term customer care. Belach offers customized and scalable bioreactors ranging 1L - 5000L with state-of-the-art computer control and latest process analytical technology.',\n",
       "  u'08-4709250',\n",
       "  u'http://www.belach.se',\n",
       "  u'info@belach.se',\n",
       "  u'Dumperv\\xe4gen 8\\n14250 Skog\\xe5s',\n",
       "  (u'Category', u'Suppliers (Manufactures)'),\n",
       "  (u'Looking for capital', u'Yes'),\n",
       "  (u'Founded', u'1985'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Revenue', u'11 MSEK in Nordic countries'),\n",
       "  (u'Number of employees', u'5'),\n",
       "  (u'Chairman', u'Lars M\\xf6rtsell'),\n",
       "  (u'Principal owners', u'Lars M\\xf6rtsell, Gy\\xf6rgy Rajkai')],\n",
       " [u'http://www.swedishlifesciences.se/biognos-ab',\n",
       "  u'Biognos AB',\n",
       "  u'Virtual Screening - Drug Discovery',\n",
       "  u'G\\xf6teborg',\n",
       "  u'Biotech',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/849/logo/biognos_ab-logo_high.jpg?itok=EHZ35hBv',\n",
       "  '',\n",
       "  (u'Business Unit Director', u'Per-Georg Nyholm'),\n",
       "  u'Biognos provides services in computational drug design especially virtual screening (in silico-screening) and lead optimization. Using our software and our computer cluster we can quickly identify potential lead compounds in large libraries of small molecules. Our ligand-based screening allows scoffold hopping and in many cases circumvention of patents. We offer our expertise mainly to  pharmaceutical companies. We have a special competence in the design of glycomimetic compounds. Biognos also provides services for academic groups.',\n",
       "  u'031-656240',\n",
       "  u'http://www.biognos.com',\n",
       "  u'info@biognos.se',\n",
       "  u'Box 8963\\nGeneratorsgatan 1\\n40274 G\\xf6teborg',\n",
       "  (u'Category', u'Biotech'),\n",
       "  (u'Founded', u'2003'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Number of employees', u'3'),\n",
       "  (u'Chairman', u'Nina Granath'),\n",
       "  (u'Principal owners', u'Nina Granath & Per-Georg Nyholm')],\n",
       " [u'http://www.swedishlifesciences.se/biothema-ab',\n",
       "  u'BioThema AB',\n",
       "  u'We Measure Life',\n",
       "  u'Handen',\n",
       "  u'Suppliers (Manufactures)',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/657/logo/81_logo_high.jpg?itok=JLd8KwzJ',\n",
       "  '',\n",
       "  (u'CEO', u'Arne Lundin'),\n",
       "  u'BioThema uses its expertise in ATP and firefly luciferase for development and production of kits, e.g. the Microbial ATP Kit HS for the specific measurement of microbial ATP in the presence of ATP from other sources and our D-luciferin, which among 8 manufacturers has the highest activity.  BioThema applications include: 1) Rapid cell counting, cell proliferation and cytotoxicity. 2) Assays of enzymes and metabolites. 3) Reporter gene expression. 4) Hygiene monitoring in food industry and hospitals. 5) Drug discovery HTS. 6) Immunoassays. Customers include: A) Research institutes. B) Clinical diagnostics. C) Biotech industry. D) Food, beverages and water industries. E) Cleaning industry. F) Pharmaceutical industries.',\n",
       "  u'08-777 00 20',\n",
       "  u'http://www.biothema.com',\n",
       "  u'info@biothema.com',\n",
       "  u'Handens stationsv\\xe4g 17\\nSE-136 40 Handen',\n",
       "  (u'Category', u'Suppliers (Manufactures)'),\n",
       "  (u'Founded', u'1987'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Revenue', u'10 MSEK Worldwide'),\n",
       "  (u'Number of employees', u'7'),\n",
       "  (u'Chairman', u'Arne Lundin'),\n",
       "  (u'Principal owners', u'Arne Lundin and Ulrika Lundin')],\n",
       " [u'http://www.swedishlifesciences.se/business-region-g%C3%B6teborg-fdi-life-science',\n",
       "  u'Business Region G\\xf6teborg- FDI-Life Science',\n",
       "  u'\"Your Port to a Vital Region\"',\n",
       "  u'G\\xf6teborg',\n",
       "  u'Service',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1193/logo/brg_logo.jpg?itok=byJrppzm',\n",
       "  '',\n",
       "  (u'Business Unit Director', u'Iris \\xd6hrn'),\n",
       "  u'Life Science is one of the main strengths of the Gothenburg region.\\r\\nSeveral reasons why:\\r\\n\\u2013 A strong industrial sector.\\r\\n\\u2013 450 Life Science companies.\\r\\n\\u2013 World-class excellence in scientific research.\\r\\n\\u2013Long track record of innovation.\\r\\n\\u2013Significant expertise in CVD and metabolic research; medical imaging, biomaterial, orthopedics, dental implants, stem cell research and transplantation.\\r\\n\\u2013State\\u2010of\\u2010the\\u2010art incubation facilities, laboratory spaces and commercial properties.\\r\\n\\r\\nBusiness Region G\\xf6teborg creates arenas and networks where science and industry can meet. We convey contacts, make it easier for new players and provide momentum so development can continue. Quite simply, we are your link to a vital region.',\n",
       "  u'031-612402',\n",
       "  u'http://www.businessregiongoteborg.com',\n",
       "  u'iris.ohrn@businessregion.se',\n",
       "  u'http://www.swedishlifesciences.se/%40BRGGothenburg',\n",
       "  u'11119\\nNorra Hamngatan 14\\n40423 G\\xf6teborg',\n",
       "  (u'Category', u'Service'),\n",
       "  (u'Founded', u'2000'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Number of employees', u'92'),\n",
       "  (u'Principal owners', u'G\\xf6teborgs Stad'),\n",
       "  (u' BRG Establishment and Investment services',\n",
       "   u'http://www.swedishlifesciences.se/sites/default/files/gothenburg_add_0.pdf'),\n",
       "  (u' the100largestemployers.pdf',\n",
       "   u'http://www.swedishlifesciences.se/sites/default/files/the100largestemployers_1.pdf'),\n",
       "  (u' brg_lookingforgoodcompany_eng.pdf',\n",
       "   u'http://www.swedishlifesciences.se/sites/default/files/brg_lookingforgoodcompany_eng.pdf')],\n",
       " [u'http://www.swedishlifesciences.se/clinstorage-ab',\n",
       "  u'ClinStorage AB',\n",
       "  u'A GMP certified storage facility',\n",
       "  u'Solna, Sweden',\n",
       "  u'Service',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1196/logo/clinstoragey.png?itok=KNqMAjCb',\n",
       "  '',\n",
       "  (u'CEO', u'Ola Camber'),\n",
       "  u'For your valuable biological and pharmaceutical materials, we provide unique quality service with in depth knowledge making us highly suitable for clients\\xb4 entire need for storage, dispensing, release and distribution: Storage from room temperature down to -150\\xba C and liquid nitrogen, Dispensing, labeling and packaging, Transportation and cold chain logistics, Batch release and certification (QP Release), Batch certification of imported medicinal products including 3rd countries and GMP audits. All service include high security with facility access and temperature control 24/7, including energy backup. ClinStorage is GMP certified by the Swedish Medical Products Agency.',\n",
       "  u'070-5180014',\n",
       "  u'http://www.clinstorage.se',\n",
       "  u'info@clinstorage.se',\n",
       "  u'Banvaktsv\\xe4gen 22\\n17148 Solna, Sweden',\n",
       "  (u'Category', u'Service'),\n",
       "  (u'Looking for capital', u'Yes'),\n",
       "  (u'Founded', u'2008'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u' ClinStorage Information Folder',\n",
       "   u'http://www.swedishlifesciences.se/sites/default/files/clinstorage_folder_english_0.pdf')],\n",
       " [u'http://www.swedishlifesciences.se/clintec-international-ltd',\n",
       "  u'ClinTec International Ltd.',\n",
       "  u'Global reach with local expertise',\n",
       "  u'G\\xf6teborg',\n",
       "  u'CROs',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1096/logo/3851_logo_high.jpg?itok=lzL36AAS',\n",
       "  '',\n",
       "  (u'CEO', u'Rabinder Buttar'),\n",
       "  u'ClinTec International is a full service CRO providing high quality, flexible clinical research solutions since 1997.  Our pioneering approach has resulted in exceptional growth in over 40 countries worldwide while allowing us to maintain local management presences.  We have experience in all major therapeutic areas as well as orphan indications.  We can support or manage any Phase I-IV, BE, BA or medical device study.  We handle patient support to meet your timelines.  ClinTec is an ideal partner for start up biotechs, SME\\xb4s, Medtech and Pharma organisations throughout the development process.',\n",
       "  u'031-277 477',\n",
       "  u'http://www.clintec.com',\n",
       "  u'northerneurope@clintec.com',\n",
       "  u'https://www.facebook.com/pages/ClinTec-International/167083426673767',\n",
       "  u'http://www.swedishlifesciences.se/%40ClinTecGlobal',\n",
       "  u'Lilla Bommen 6\\n41104 G\\xf6teborg',\n",
       "  (u'Category', u'Contract Research Organisations'),\n",
       "  (u'Founded', u'1997'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Number of employees', u'350'),\n",
       "  (u'Principal owners', u'Rabinder Buttar')],\n",
       " [u'http://www.swedishlifesciences.se/copenhagen-bio-science-park',\n",
       "  u'Copenhagen Bio Science Park',\n",
       "  u'Copenhagen Bio Science Park',\n",
       "  u'Copenhagen N',\n",
       "  u'Service',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1217/logo/cobis_logo.jpg?itok=ehtRwyi8',\n",
       "  '',\n",
       "  (u'CEO', u'Morten M\\xf8lgaard Jensen'),\n",
       "  u\"COBIS is centrally located in Copenhagen in an environment of excellence when it comes to knowledge and commercial use of biotechnology, medicine, and pharmacology. The space is exceptional. A 12,000 square meter building of modern architecture with lab facilities and offices.\\r\\n\\r\\nWe have something to offer you regardless of whether you represent an established life science company, a CRO , or even if you simply have a good idea and need help to get started.\\r\\n\\r\\nOur location is ideal. We are centrally located between Denmark\\u2019s leading hospitals and major universities \\u2013 in the heart of the world's strongest biotech region, Medicon Valley and only minutes away from the centre of Copenhagen.\",\n",
       "  u'+4570702980',\n",
       "  u'http://www.cobis.dk',\n",
       "  u'info@cobis.dk',\n",
       "  u'Ole Maaloes Vej 3\\n2200 Copenhagen N',\n",
       "  (u'Category', u'Service'),\n",
       "  (u'Founded', u'2011'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Number of employees', u'6'),\n",
       "  (u'Chairman', u'Steen Donner'),\n",
       "  (u'Principal owners', u'Scion DTU, Symbion Science Park')],\n",
       " [u'http://www.swedishlifesciences.se/ctc-clinical-trial-consultants-ab',\n",
       "  u'CTC Clinical Trial Consultants AB',\n",
       "  u'Translating science into treatment',\n",
       "  u'Uppsala',\n",
       "  u'CROs',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1139/logo/ctc-logotyp-liggande-stor.jpg?itok=M_4dPJ29',\n",
       "  '',\n",
       "  (u'CEO', u'Anders Millerhovf'),\n",
       "  u'CTC AB is a privately owned CRO with focus on clinical conduct of hospital-based early phase clinical trials (phase 0/I IIa) in patients and healthy volunteers in a dedicated 12-bed research clinic at the University hospital in Uppsala combined with two SMO sites in Uppsala and Link\\xf6ping for phase II/III studies. \\r\\nThe research clinic at the University hospital in Uppsala is approved by the Medical Products Agency for First-in-Human studies. \\r\\nOur experts can support your company throughout the translational phase to get an early indication of proof of mechanism/concept in patients/volunteers.',\n",
       "  u'+46-768-33 98 88',\n",
       "  u'http://www.ctc-ab.se',\n",
       "  u'anders.millerhovf@ctc-ab.se',\n",
       "  u'Dag Hammarskj\\xf6lds v\\xe4g 13\\n752 37 Uppsala',\n",
       "  (u'Category', u'Contract Research Organisations'),\n",
       "  (u'Founded', u'2011'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Revenue', u'22 MSEK in Sweden'),\n",
       "  (u'Number of employees', u'15'),\n",
       "  (u'Chairman', u'Bengt Dahlstr\\xf6m'),\n",
       "  (u'Principal owners', u'Private')],\n",
       " [u'http://www.swedishlifesciences.se/hansa-medical-ab-publ',\n",
       "  u'Hansa Medical AB (publ)',\n",
       "  u'Enabling transplantation',\n",
       "  u'Lund',\n",
       "  u'Biotech',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/999/logo/hmed_logo.jpg?itok=IY_arsgW',\n",
       "  '',\n",
       "  (u'CEO', u'G\\xf6ran Arvidson'),\n",
       "  u'Hansa Medical is a biopharmaceutical company focused on novel immunomodulatory enzymes. Its lead project IdeS is an antibody-degrading enzyme in Phase II clinical development, with potential use in transplantation and rare autoimmune diseases.\\r\\n\\r\\nOther projects include HBP-assay, a market-launched diagnostic marker for severe sepsis, and EndoS, an antibody-modulating bacterial en\\xaczyme in pre-clinical development. The company is based in Lund, Sweden. Hansa Medical\\u2019s share (HMED) is listed on Nasdaq First North in Stockholm, with Remium Nordic AB as Certified Adviser.',\n",
       "  u'046-165670',\n",
       "  u'http://www.hansamedical.com',\n",
       "  u'info@hansamedical.com',\n",
       "  u'Scheelev\\xe4gen 22\\nBox 785\\n220 07 Lund',\n",
       "  (u'Category', u'Biotech'),\n",
       "  (u'Founded', u'2007'),\n",
       "  (u'Public company', u'Yes'),\n",
       "  (u'Revenue', u'4.7 MSEK in Sweden'),\n",
       "  (u'Number of employees', u'14'),\n",
       "  (u'Chairman', u'Birgit Stattin Norinder'),\n",
       "  (u'Principal owners', u'NXT2B')],\n",
       " [u'http://www.swedishlifesciences.se/intervacc-ab',\n",
       "  u'Intervacc AB',\n",
       "  u'Utveckling av vacciner inom djurh\\xe4lsa',\n",
       "  u'H\\xe4gersten',\n",
       "  u'Biotech',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1239/logo/logo_horizontal_rgb.jpg?itok=qgSQOINn',\n",
       "  '',\n",
       "  (u'CEO', u'Jan-Ingmar Flock'),\n",
       "  u'Intervacc arbetar med att utveckla nya vacciner mot bakteriella infektioner, framf\\xf6r allt inom veterin\\xe4romr\\xe5det. Fokus ligger i fr\\xe4msta hand p\\xe5 att ta fram ett vaccin mot Streptococcus equi som orsakar kvarka p\\xe5 h\\xe4st. Detta \\xe4r en mycket smittsam och allvarlig infektion som medf\\xf6r mycket h\\xf6ga kostnader inom h\\xe4stn\\xe4ringen och behovet av ett vaccin \\xe4r d\\xe4rf\\xf6r stort. Vaccinet som Intervacc utvecklat (Strangvac) baseras p\\xe5 rekombinanta proteiner  och har d\\xe4rf\\xf6r en mycket god s\\xe4kerhetsprofil utan biverkningar. Strangvac genomg\\xe5r f\\xf6r n\\xe4rvarande slutliga kliniska pr\\xf6vningar. Intervacc f\\xf6rv\\xe4rvade under 2014 Nordvacc L\\xe4kemedel som ing\\xe5r som dotterbolag i koncernen. Nordvacc arbetar med f\\xf6rs\\xe4ljning av veterin\\xe4ra l\\xe4kemedel och vacciner.',\n",
       "  u'08-12010602',\n",
       "  u'http://intervacc.com',\n",
       "  u'jan-ingmar.flock@intervacc.com',\n",
       "  u'Box 112\\n12922 H\\xe4gersten',\n",
       "  (u'Category', u'Biotech'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Chairman', u'Rune Bergman')],\n",
       " [u'http://www.swedishlifesciences.se/irw-consulting-ab',\n",
       "  u'IRW Consulting AB',\n",
       "  u'Your preferred Nordic CRO',\n",
       "  u'Danderyd',\n",
       "  u'CROs',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/986/logo/737_logo_high.jpg?itok=WwhP90Fx',\n",
       "  '',\n",
       "  (u'CEO', u'Ingela Wiking'),\n",
       "  u'IRW is a Nordic full-service CRO with our own offices and staff in Sweden, Denmark, Norway and Finland with more than 15 years of experience of Clinical Research Outsourcing in Scandinavia. We offer cost efficient services in Clinical Operations, Project Management, Data Management/ePRO, Biostatistics, Pharmacovigilance, Regulatory and Medical Writing for a large range of customers in Biotech and Big Pharma. IRW has ongoing assignments in all development phases. Our studies run in the Nordics as well as in other regions with the assistance of our well established CRO partner network. IRW\\u2019s dynamic approach to the changing clinical trials environment makes us uniquely positioned as the preferred Nordic CRO.',\n",
       "  u'08-7916640',\n",
       "  u'http://www.irwcro.com',\n",
       "  u'info@irwcro.com',\n",
       "  u'Box 703\\nSv\\xe4rdv\\xe4gen 3A\\n182 17 Danderyd',\n",
       "  (u'Category', u'Contract Research Organisations'),\n",
       "  (u'Founded', u'1999'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Revenue', u'50 MSEK in Nordic countries'),\n",
       "  (u'Number of employees', u'40'),\n",
       "  (u'Chairman', u'Tommy Adamsson'),\n",
       "  (u'Principal owners', u'Ingela Wiking')],\n",
       " [u'http://www.swedishlifesciences.se/karolinska-development-ab',\n",
       "  u'Karolinska Development AB',\n",
       "  '',\n",
       "  u'Solna',\n",
       "  u'Business Development',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/810/logo/kd_logo_large.jpg?itok=nZjz6bLN',\n",
       "  '',\n",
       "  (u'CEO', u'Jim Van heusden'),\n",
       "  u'Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into differentiated products that can be partnered. The business model is to: SELECT the most commercially attractive medical innovations that can potentially satisfy unmet medical needs; DEVELOP innovations to the stage where the greatest return on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.',\n",
       "  u'08-524 860 70',\n",
       "  u'http://www.karolinskadevelopment.com',\n",
       "  u'info@karolinskadevelopment.com',\n",
       "  u'Tomtebodav\\xe4gen 23 A\\n17165 Solna',\n",
       "  (u'Category', u'Business Development'),\n",
       "  (u'Founded', u'2003'),\n",
       "  (u'Public company', u'Yes'),\n",
       "  (u'Number of employees', u'10'),\n",
       "  (u'Chairman', u'Bo Jesper Hansen'),\n",
       "  (u'Principal owners', u'More than 3000 shareholders')],\n",
       " [u'http://www.swedishlifesciences.se/karolinska-institutet-innovations-ab',\n",
       "  u'Karolinska Institutet Innovations AB',\n",
       "  '',\n",
       "  u'Solna',\n",
       "  u'Business Development',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/788/logo/karolinska_institutet_innovations_ab-logo_low.jpg?itok=djxGA8sR',\n",
       "  '',\n",
       "  (u'CEO', u'Lilian Wikstr\\xf6m'),\n",
       "  u'KI Innovations turns promising biomedical research into new products and applications to improve global health and well being. KI Innovations drives the development process by providing project management, funding for patent protection, legal advice, business development and has an extensive network with the international pharmaceutical industry. KI Innovations has reviewed more than 1400 academic innovations, created 40 start-ups and has signed 35 license agreements. KI Innovations has a close collaboration with the Karolinska Development AB.',\n",
       "  u'08-5248 36 51',\n",
       "  u'http://www.kiinnovations.se',\n",
       "  u'info@karolinskainnovations.ki.se',\n",
       "  u'Tomtebodav\\xe4gen 23\\n171 65 Solna',\n",
       "  (u'Category', u'Business Development'),\n",
       "  (u'Founded', u'1996'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Number of employees', u'8'),\n",
       "  (u'Chairman', u'Magnus Persson'),\n",
       "  (u'Principal owners', u'Karolinska Institutet Holding AB')],\n",
       " [u'http://www.swedishlifesciences.se/karolinska-institutet-science-park-ab',\n",
       "  u'Karolinska Institutet Science Park AB',\n",
       "  u'A business-enabling milieu',\n",
       "  u'Solna',\n",
       "  u'Service',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1047/logo/3569_logo_high.jpg?itok=NCMXPFVU',\n",
       "  '',\n",
       "  (u'CEO', u'M\\xe4rit Johansson'),\n",
       "  u\"Based at Karolinska Institutet's campuses, KI Science Park is the home to over 80 companies, operating in healthcare, pharmaceutical, diagnostics and medical technologies. Proximity to cutting-edge research and education, world-leading University hospitals and an unrivalled, dynamic milieu for commercializing research concepts are factors that make the extraordinary environment. The Park offers office premises, laboratory facilities and life science-specific support, to facilitate companies\\u2019 challenging journey to success.\",\n",
       "  u'070-872 35 32',\n",
       "  u'http://www.sciencepark.ki.se',\n",
       "  u'marit.johansson@kisciencepark.se',\n",
       "  u'Tomtebodav\\xe4gen 23a\\n17165 Solna',\n",
       "  (u'Category', u'Service'),\n",
       "  (u'Founded', u'2006'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Number of employees', u'4'),\n",
       "  (u'Chairman', u'Hans M\\xf6ller'),\n",
       "  (u'Principal owners', u'Karolinska Institutet Holding AB')],\n",
       " [u'http://www.swedishlifesciences.se/kemwell-ab',\n",
       "  u'Kemwell AB',\n",
       "  u'CDMO services with turn key solutions',\n",
       "  u'Uppsala',\n",
       "  u'CMOs',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1014/logo/802_logo_low.jpg?itok=oiYYaww8',\n",
       "  '',\n",
       "  (u'CEO', u'Agneta Bergvall'),\n",
       "  u'Kemwell operates manufacturing facilities in India and Sweden and employing 1000 people worldwide. \\r\\nWe are a family-owned company, with a focus on long term strategies. \\r\\nKemwell is a provider of contract manufacturing and development services for the pharmaceutical- and biotech industry globally.\\r\\nKemwell is your ideal strategic partner in:\\r\\n\\u2022 Formulation development\\r\\n\\u2022 Analytical support\\r\\n\\u2022 Clinical batch production\\r\\n\\u2022 EU gateway release\\r\\n\\u2022 Commercial-scale  manufacturing\\r\\n\\u2022 Packaging\\r\\n\\u2022 Distribution world wide\\r\\n\\u2022 One-stop shop solutions',\n",
       "  u'018-164000',\n",
       "  u'http://www.kemwellbiopharma.com',\n",
       "  u'info@kemwell.se',\n",
       "  u'Rapsgatan 7\\n75182 Uppsala',\n",
       "  (u'Category', u'Contract Manufacturing Organisations'),\n",
       "  (u'Founded', u'2006'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Revenue', u'380 MSEK in Sweden'),\n",
       "  (u'Number of employees', u'180'),\n",
       "  (u'Chairman', u'Per\\xc5ke Oldentoft'),\n",
       "  (u'Principal owners', u'Kemwell Biopharma Pvt Ltd')],\n",
       " [u'http://www.swedishlifesciences.se/ladulaas-clinical-trials',\n",
       "  u'Ladulaas Clinical Trials',\n",
       "  u'Specialized in Clinical Trials',\n",
       "  u'Boras/Gothenburg',\n",
       "  u'CROs',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1167/logo/ladulaas-kliniska_studier.jpg?itok=DdupD42I',\n",
       "  '',\n",
       "  (u'CEO', u'Katarina Berndtsson Blom'),\n",
       "  u'Our team is educated and trained in ICH-GCP and we are long experienced in conducting clinical trials, phase II to V.\\r\\n\\r\\nWe have been working together with most of the major global pharmaceutical and CRO companies and we also cooperate with medical faculties all over the world.\\r\\n\\r\\nWe know the importance of fast recruitment, well treatment and security to make the participants fulfill the whole protocol. We have participated in trials from migraine to onychomycosis\\u2026.\\r\\n\\r\\nTry us for Trials!',\n",
       "  u'033-13 13 31',\n",
       "  u'http://www.ladulaaskliniken.se',\n",
       "  u'info@ladulaaskliniken.se',\n",
       "  u'Skaraborgsv\\xe4gen 35E\\n506 30 Boras/Gothenburg',\n",
       "  (u'Category', u'Contract Research Organisations'),\n",
       "  (u'Founded', u'2007'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Number of employees', u'5'),\n",
       "  (u'Chairman', u'Katarina Berndtsson Blom'),\n",
       "  (u'Principal owners', u'Family owned company')],\n",
       " [u'http://www.swedishlifesciences.se/mannheimer-swartling-advokatbyr%C3%A5',\n",
       "  u'Mannheimer Swartling Advokatbyr\\xe5',\n",
       "  u'Your legal Life Sciences partner',\n",
       "  u'Stockholm',\n",
       "  u'Intellectual Property',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1054/logo/logo_vansterstalld.jpg?itok=KkFkEAuU',\n",
       "  '',\n",
       "  (u'Business Unit Director', u'Hel\\xe9n Waxberg'),\n",
       "  u'Mannheimer Swartling is the leading business law firm in the Nordic region. We are a full service firm with an extensive international experience. Our Life Science team has longstanding and extensive experience in the Life Science sector and advises in all areas from research and development to market authorisation and distribution of the final product and life cycle management issues. Our clients include multinational corporations as well as start-ups and other entrepreneurial ventures in the pharmaceutical, biotechnical, medical devices and food industry.',\n",
       "  u'08-59506000',\n",
       "  u'http://www.mannheimerswartling.se',\n",
       "  u'Box 1711\\nNorrlandsgatan 21\\n11187 Stockholm',\n",
       "  (u'Category', u'Intellectual Property'),\n",
       "  (u'Public company', u'No')],\n",
       " [u'http://www.swedishlifesciences.se/medeon-ab',\n",
       "  u'Medeon AB',\n",
       "  u'The best location in Medicon Valley',\n",
       "  u'Malm\\xf6',\n",
       "  u'Service',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1173/logo/logo_medeon_ny.jpg?itok=WVJHm2ZU',\n",
       "  '',\n",
       "  (u'CEO', u'Ulf G Andersson'),\n",
       "  u'Medeon Scienc Park provides a creative environment for new and established companies. Our focus is directed at knowledge-intensive businesses within life science: pharmaceutical development, medical technology, biotechnology and health care. At Medeon you gain access to:\\r\\n\\r\\nSuitable premises with the opportunity to build new facilities\\r\\n\\r\\nClose cooperation with health care and the University\\r\\n\\r\\nStrong network and incubator functions\\r\\n\\r\\nGood services with, for example, reception, switchboard, travel agency and restaurant',\n",
       "  u'040-321022',\n",
       "  u'http://www.medeon.se',\n",
       "  u'catrine.pauckstadt@medeon.se',\n",
       "  u'https://www.facebook.com/MedeonSciencePark',\n",
       "  u'Medeon Science Park\\nPer Albin Hanssons v\\xe4g 41\\n20512 Malm\\xf6',\n",
       "  (u'Category', u'Service'),\n",
       "  (u'Founded', u'1985'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Number of employees', u'3')],\n",
       " [u'http://www.swedishlifesciences.se/medicago-ab',\n",
       "  u'Medicago AB',\n",
       "  u'Your Trusted Partner in Biotech',\n",
       "  u'Uppsala',\n",
       "  u'CMOs',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/647/logo/67_logo_high.jpg?itok=O8kDQqZN',\n",
       "  '',\n",
       "  (u'CEO', u'Jan Henriksson'),\n",
       "  u'Founded in 1995 in Uppsala, Sweden, Medicago is celebrating 20 years of continuous service to the life-science and biotechnology industry. We are privately-owned, enthusiastic, and operate throughout the world. We keep quality in focus (ISO 9001 and ISO 13485 certified). Medicago is active both as a CRO/CMO (contract research/manufacturing organisation) as well as a worldwide provider of our own biotech products.\\r\\nWe offer contract development/manufacturing and customized services. We have facilities for aseptic filling and freeze drying.\\r\\nOur own products comprises user-friendly reagents SmartBuffers\\u2122 (pre-made dry buffers), Lectins, as well as research and biochemical kits and reagents. Bulk amounts are available on request.',\n",
       "  u'018-56 11 80',\n",
       "  u'http://www.medicago.se',\n",
       "  u'info@medicago.se',\n",
       "  u'Danmark Berga 13\\n755 98 Uppsala',\n",
       "  (u'Category', u'Contract Manufacturing Organisations'),\n",
       "  (u'Founded', u'1995'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Revenue', u'25 MSEK Worldwide'),\n",
       "  (u'Number of employees', u'23'),\n",
       "  (u'Chairman', u'Emil Linde')],\n",
       " [u'http://www.swedishlifesciences.se/medicon-village',\n",
       "  u'Medicon Village',\n",
       "  u'For people\\xb4s health and well-being',\n",
       "  u'Lund',\n",
       "  u'Service',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1211/logo/mv_logo2_rgb_2.png?itok=gA4Iejo6',\n",
       "  '',\n",
       "  (u'CEO', u'Mats Leifland '),\n",
       "  u'Medicon Village is a life science village for research, innovation and business for people\\xb4s health and wellbeing. Today we house 1200 people in more than 100 organisations working in pharma, medtech, biotech, nano- and e-health. Medicon Village is a progressive platform for cutting-edge research and innovation in the fields of prevention, diagnostics, treatment and care. We believe that interdisciplinary exchange is a key driver in creating growth. Medicon Village is a venue for exchange of ideas, hosting a large number of life science seminars and events. \\r\\n\\r\\nWelcome to visit Medicon Village\\xb4s high quality laboratories and offices, all with full service to create your breeding ground for successful development and growth.',\n",
       "  u'046-275 60 00',\n",
       "  u'http://www.mediconvillage.se',\n",
       "  u'info@mediconvillage.se',\n",
       "  u'http://www.facebook.com/MediconVillage',\n",
       "  u'Medicon Village AB\\n223 81 Lund',\n",
       "  (u'Category', u'Service'),\n",
       "  (u'Looking for capital', u'Yes'),\n",
       "  (u'Founded', u'2012'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Number of employees', u'25'),\n",
       "  (u'Chairman', u'G\\xf6ran Grosskopf'),\n",
       "  (u'Principal owners',\n",
       "   u'Mats Paulsson Foundation for research, innovation and societal development.')],\n",
       " [u'http://www.swedishlifesciences.se/mercodia-ab',\n",
       "  u'Mercodia AB',\n",
       "  u'Developer of immunoassays',\n",
       "  u'Uppsala',\n",
       "  u'Suppliers (Manufactures)',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/690/logo/133_logo_low.gif?itok=adRfyhqp',\n",
       "  '',\n",
       "  (u'CEO', u'Mona \\xd6sterberg'),\n",
       "  u'Mercodia AB is a Swedish biotech company focusing on the development of immunoassays for research within the field of metabolic disorders, cardiovascular disease and diabetes. Our assays are applicable to both animal and human models and are used for research ranging from basic scientific studies to large pre-clinical and clinical phase trials. The company was founded in 1991 and is today a world-leading supplier of products to all major international markets. More than ninety percent of our production is exported from our facilities in Uppsala to approximately 100 different countries around the world.',\n",
       "  u'018-570070',\n",
       "  u'http://www.mercodia.com',\n",
       "  u'info@mercodia.com',\n",
       "  u'http://www.facebook.com/mercodia?fref=ts',\n",
       "  u'-\\nSylveniusgatan 8A\\n75450 Uppsala',\n",
       "  (u'Category', u'Suppliers (Manufactures)'),\n",
       "  (u'Founded', u'1991'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Revenue', u'61 MSEK Worldwide'),\n",
       "  (u'Number of employees', u'52'),\n",
       "  (u'Chairman', u'Erling Holmlund'),\n",
       "  (u'Principal owners', u'Erling Holmlund')],\n",
       " [u'http://www.swedishlifesciences.se/metasafe-ab',\n",
       "  u'MetaSafe AB',\n",
       "  u'Metasafe - Metabolites in Safety Testing',\n",
       "  u'S\\xf6dert\\xe4lje',\n",
       "  u'Service',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1235/logo/metasafe_logo.jpg?itok=SBlLfAO8',\n",
       "  '',\n",
       "  (u'CEO', u'Johanna Haglund'),\n",
       "  u'MetaSafe AB is a partner laboratory offering high qualitative mass-spectrometric analyses to reveal biotransformation and metabolism characteristics of drugs during all stages of pharmaceutical development. MetaSafe is situated in the Biovation Park Telge in S\\xf6dert\\xe4lje.\\r\\nMetaSafe provides any pharmaceutical company or academic group design and execution of exploratory, problem-solving, non-regulatory or regulatory biotransformation studies that enable progression of their drug projects.',\n",
       "  u'0767-797734',\n",
       "  u'http://www.metasafe.se/',\n",
       "  u'Johanna.Haglund@metasafe.se',\n",
       "  u'Forskargatan 20J\\n151 36 S\\xf6dert\\xe4lje',\n",
       "  (u'Category', u'Service'),\n",
       "  (u'Founded', u'2012'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Number of employees', u'3')],\n",
       " [u'http://www.swedishlifesciences.se/mikrolab-stockholm-ab-0',\n",
       "  u'Mikrolab Stockholm AB',\n",
       "  u'GMP certified Microbiology Laboratory',\n",
       "  u'Sollentuna',\n",
       "  u'Service',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1212/logo/logga2.png?itok=BYAjRXVO',\n",
       "  '',\n",
       "  (u'CEO', u'Adam Mallkoo'),\n",
       "  u'Mikrolab is a leading provider of contract microbiology services to the pharmaceutical-, cosmetic- and medical device industry. We support you in every phase of your development and manufacturing process from raw material testing to final product release testing. \\r\\n\\r\\nWe have a GMP certificate from the Swedish Medical Products Agency and a ISO 17025 Accreditation. \\r\\n\\r\\n- We perform sterility testing in our clean room GMP grade A -\\r\\n- Total count and Bioburden testing -\\r\\n- Endotoxin Detection -\\r\\n- We perform tests for specific microorganisms -\\r\\n- Closure Integrity studies, Bacterological and blue dye ingress -\\r\\n- Customer specific studies and many other laboratory services -\\r\\nAffiliate company: MKL Diagnostics AB\\r\\nwww.mikrolab.se',\n",
       "  u'08-297900',\n",
       "  u'http://www.vattenprovtagning.se',\n",
       "  u'fredrik.johansson@mikrolab.se',\n",
       "  u'https://www.facebook.com/vattenprovtagning',\n",
       "  u'Kung Hans V\\xe4g 3\\n192 68 Sollentuna',\n",
       "  (u'Category', u'Service'),\n",
       "  (u'Founded', u'1974'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Number of employees', u'15'),\n",
       "  (u'Chairman', u'Fredrik Johansson'),\n",
       "  (u'Principal owners', u'Adam Mallkoo, Fredrik Johansson')],\n",
       " [u'http://www.swedishlifesciences.se/nda-group-ab',\n",
       "  u'NDA Group AB',\n",
       "  u'Drug Development Consultancy',\n",
       "  u'Upplands V\\xe4sby',\n",
       "  u'Service',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/693/logo/139_logo_high_0.jpg?itok=-UBgdblm',\n",
       "  '',\n",
       "  (u'CEO', u'Johan Str\\xf6mquist'),\n",
       "  u'We support life science companies all over the world and across all phases of development, from pre-clinical to post marketing, to the needs and requirements of regulators and payers alike. We work together with our clients to address key strategic regulatory and reimbursement challenges. Our scientific expertise covers all major therapeutic areas.\\r\\n\\r\\nThe advice you get from NDA is from real experts in the industry, many who have been involved in shaping today\\u2019s regulatory, HTA and pharmacovigilance environment. We have close to 100 employees across Europe. More than 25% are ex EU regulators.\\r\\n\\r\\nWith our support, you can cut the time and associated cost it takes to get your products to market, and keep them there.',\n",
       "  u'08-590 77 800',\n",
       "  u'http://www.ndareg.com',\n",
       "  u'info@ndareg.com',\n",
       "  u'https://twitter.com/ndagroup',\n",
       "  u'Johanneslundsv\\xe4gen 2\\n19481 Upplands V\\xe4sby',\n",
       "  (u'Category', u'Service'),\n",
       "  (u'Founded', u'1997'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Revenue', u'150 MSEK in Europe'),\n",
       "  (u'Number of employees', u'100'),\n",
       "  (u'Chairman', u'Lars-Helge Str\\xf6mquist'),\n",
       "  (u'Principal owners', u'Lars-Helge Str\\xf6mquist, Christina Str\\xf6mquist')],\n",
       " [u'http://www.swedishlifesciences.se/nordic-biolabs-ab',\n",
       "  u'Nordic Biolabs AB',\n",
       "  u'New technologies at customers desk',\n",
       "  u'T\\xe4by',\n",
       "  u'Suppliers (Distributors)',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/787/logo/290_logo_low.jpg?itok=NsQZQ3QU',\n",
       "  '',\n",
       "  (u'CEO', u'Thomas Busch'),\n",
       "  u'Nordic Biolabs AB represents leading brands in our 4 business areas: Biotechnology, Transfusion Medicine, Clinical Diagnostics and Industrial Microbiology/Hygien Controle.\\r\\nNordic Biolabs shall through a combination of competence and a well balanced product portfolio offer customers an unique partnership and participate in the technical development. We keep this statement vivid every day by introducing new products, finding new innovative suppliers, giving lectures and seminars and always be keen on our customers needs',\n",
       "  u'08-6308500',\n",
       "  u'http://www.nordicbiolabs.se',\n",
       "  u'info@nordicbiolabs.se',\n",
       "  u'https://www.facebook.com/NordicBiolabs',\n",
       "  u'Box 7293\\nRitarslingan 16\\n18714 T\\xe4by',\n",
       "  (u'Category', u'Suppliers (Distributors)'),\n",
       "  (u'Founded', u'1970'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Revenue', u'58 MSEK in Nordic countries'),\n",
       "  (u'Number of employees', u'19'),\n",
       "  (u'Chairman', u'Jan Skaring'),\n",
       "  (u'Principal owners', u'Jan Skaring, Claes Hedberg, Thomas Busch')],\n",
       " [u'http://www.swedishlifesciences.se/optimize-courier-sweden-ab',\n",
       "  u'Optimize Courier (Sweden) AB',\n",
       "  u'Logistics,Cold Chain Packaging Solutions',\n",
       "  u'Arlandastad',\n",
       "  u'Suppliers (Distributors)',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1011/logo/logo.jpg?itok=ZfPjojYA',\n",
       "  '',\n",
       "  (u'CEO', u'Jan Karlsson'),\n",
       "  u'Optimize Courier is a global specialty and GDP compliant courier company dedicated to the worldwide coordination & transportation of biological, pharmaceutical, time critical and cold chain logistics. Operating 24 hours a day, 7 days a week with decades of experience behind us, we promise to go the extra mile every day to ensure you receive the highest level of service and value with each shipment you entrust to us.',\n",
       "  u'08-59450110',\n",
       "  u'http://www.optimizecourier.com',\n",
       "  u'ops@optimizecourier.se',\n",
       "  u'https://www.facebook.com/pages/Optimize-Courier-Official/257521767789790',\n",
       "  u'Visiting address\\nMaskingatan 17C\\n19560 Arlandastad',\n",
       "  (u'Category', u'Suppliers (Distributors)'),\n",
       "  (u'Founded', u'2007'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Number of employees', u'8'),\n",
       "  (u'Principal owners', u'Jan Karlsson')],\n",
       " [u'http://www.swedishlifesciences.se/pharma-consulting-group-ab',\n",
       "  u'Pharma Consulting Group AB',\n",
       "  u'The CRO where knowledge meets technology',\n",
       "  u'Uppsala',\n",
       "  u'CROs',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/805/logo/pharma_consulting_group_ab-logo_low.gif?itok=_mACgE2E',\n",
       "  '',\n",
       "  (u'CEO', u'Andy Babington'),\n",
       "  u'PCG Clinical Services is a Scandinavian full-service CRO with established collaborations with organisations, enabling us to provide full service coverage for our customers \\u2013 locally and globally. We combine front-line technology with CRO-services featuring requirements needed for data handling, analysis and reporting for customers in the pharma/biotech arena and academia. Our experienced project managers and biometric experts is the cornerstone of PCG, and has enabled us to develop services within monitoring, medical writing and pharmacovigilance. Our in-house developed EDC system Viedoc is used throughout our services and enables us and our customers to do things better. We work with the world\\u2019s most advanced and demanding companies.',\n",
       "  u'018-4303100',\n",
       "  u'http://www.PharmaConsultingGroup.com',\n",
       "  u'info@pharmaconsultinggroup.com',\n",
       "  u'Kungs\\xe4ngsv\\xe4gen 19\\n75323 Uppsala',\n",
       "  (u'Category', u'Contract Research Organisations'),\n",
       "  (u'Founded', u'2003'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Revenue', u'70 MSEK Worldwide'),\n",
       "  (u'Number of employees', u'50'),\n",
       "  (u'Principal owners', u'The founders')],\n",
       " [u'http://www.swedishlifesciences.se/pharmanest-ab',\n",
       "  u'Pharmanest AB',\n",
       "  '',\n",
       "  u'Solna',\n",
       "  u'Pharma',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1118/logo/pharmanestlogo-color.jpg?itok=oZW4BHiG',\n",
       "  '',\n",
       "  (u'CEO', u'Gunilla Lundmark'),\n",
       "  u\"Pharmanest is developing unique pain relief formulations based on well-known active substances. The formulations are applied topically in the cervix and uterus using applicators developed in-house. Pain relief is obtained immediately, no advanced instrumentation is required and the systemic effect is minimized. Pharmanest's first product candidate has been developed for use in local pain relief in connection with the insertion of IUDs. With its candidate products. Pharmanest hopes to be able to offer effective local pain relief which is advantageous from both the patient and health economics perspectives.\",\n",
       "  u'08-524 84702',\n",
       "  u'http://www.pharmanest.se',\n",
       "  u'info@pharmanest.se',\n",
       "  u'Karolinska Institutet Science Park, Retzius v\\xe4g 8, 171 65 Solna\\n17165 Solna',\n",
       "  (u'Category', u'Pharma'),\n",
       "  (u'Looking for capital', u'Yes'),\n",
       "  (u'Founded', u'2009'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Number of employees', u'3'),\n",
       "  (u'Chairman', u'Alan Raffensperger'),\n",
       "  (u'Principal owners', u'Karolinska Development AB')],\n",
       " [u'http://www.swedishlifesciences.se/polypeptide-laboratories-ab',\n",
       "  u'PolyPeptide Laboratories AB',\n",
       "  u'GMP manufacture of peptides',\n",
       "  u'Limhamn',\n",
       "  u'Suppliers (Manufactures)',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/748/logo/226_logo_high.jpg?itok=xI18BLm1',\n",
       "  '',\n",
       "  (u'Business Unit Director', u'Jan Christensen'),\n",
       "  u'The PolyPeptide Group specializes in contract GMP manufacturing of peptide therapeutics. In consultation with the customer, Polypeptide Group can examine several potentially commercially relevant manufacturing strategies, and proceed by conducting a pilot manufacturing study. This can be followed by scaling-up the optimized strategy, stepwise introduction of GMP, process validation, progress to registration lots, stability studies and compilation of an appropriate US or European drug master file.',\n",
       "  u'040-366200',\n",
       "  u'http://www.polypeptide.com',\n",
       "  u'ppl@polypeptide.com',\n",
       "  u'P.O. Box 30089\\nLimhamnsv\\xe4gen 108\\n20061 Limhamn',\n",
       "  (u'Category', u'Suppliers (Manufactures)'),\n",
       "  (u'Founded', u'1996'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Number of employees', u'450 worldwide'),\n",
       "  (u'Chairman', u'Jane Salik'),\n",
       "  (u'Principal owners', u'Frederik Paulsen')],\n",
       " [u'http://www.swedishlifesciences.se/recipharm-ab',\n",
       "  u'Recipharm AB',\n",
       "  u'Contract Development and Manufacturing',\n",
       "  u'Jordbro',\n",
       "  u'CMOs',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1024/logo/3424_logo_low.png?itok=oXtdFoHq',\n",
       "  '',\n",
       "  (u'CEO', u'Thomas Eldered'),\n",
       "  u'Recipharm is a leading CDMO (Contract Development and Manufacturing Organisation) in the pharmaceutical industry based in Sweden employing some 1,500 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and pharmaceutical product development. Recipharm currently manufactures more than 200 different products to both Big Pharma and smaller research- and development companies. Recipharm\\u2019s turnover is approximately SEK 2.1 billion and the Company operates development and manufacturing facilities in Sweden, France, the UK, Germany and Spain and is headquartered near Stockholm.',\n",
       "  u'08-6025200',\n",
       "  u'http://www.recipharm.com',\n",
       "  u'info@recipharm.com',\n",
       "  u'Lagerv\\xe4gen 7\\n13650 Jordbro',\n",
       "  (u'Category', u'Contract Manufacturing Organisations'),\n",
       "  (u'Founded', u'1995'),\n",
       "  (u'Public company', u'Yes'),\n",
       "  (u'Revenue', u'2100 MSEK Worldwide'),\n",
       "  (u'Number of employees', u'1500'),\n",
       "  (u'Chairman', u'Lars Backsell')],\n",
       " [u'http://www.swedishlifesciences.se/scandinavian-cro-ab',\n",
       "  u'Scandinavian CRO AB',\n",
       "  u'The CRO in Scandinavia',\n",
       "  u'Uppsala',\n",
       "  u'CROs',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1029/logo/scro_logo-black.jpg?itok=gMqWeejb',\n",
       "  '',\n",
       "  (u'CEO', u'Ulrika Hammarstr\\xf6m L\\xfcllmaa'),\n",
       "  u'Scandinavian CRO is a full service Contract Research Organisation offering both consultancy and specific, stand-alone services. Scandinavian CRO is an organization that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. From study design to study report.',\n",
       "  u'018-100550',\n",
       "  u'http://www.scro.se',\n",
       "  u'info@scro.se',\n",
       "  u'Skolgatan 8, \"box 15027\"\\n75015 Uppsala',\n",
       "  (u'Category', u'Contract Research Organisations'),\n",
       "  (u'Founded', u'2007'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Number of employees', u'22')],\n",
       " [u'http://www.swedishlifesciences.se/scandinavian-development-services-0',\n",
       "  u'Scandinavian Development Services',\n",
       "  u'Experts in drug development!',\n",
       "  u'Danderyd',\n",
       "  u'Service',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1263/logo/sds_symbol.png?itok=wPDpNSA3',\n",
       "  '',\n",
       "  (u'CEO', u'Anna T\\xf6rner'),\n",
       "  u'At Scandinavian Development Services we specialise in all regulatory and scientific aspects in the drug development process, from the initial project idea through to the completely developed product. We have expertise in formulation development, non-clinical program planning and, communication with regulatory authorities for development programs, including clinical programs. We are also experts in medical statistics!\\r\\n\\r\\nOur ambition is to solve the tricky questions which have no obvious answers. To do so we have built an experienced team of specialists within the field of drug development and biostatistics. When required, we have a network of Swedish and international experts with regulatory, medicinal and statistical expert knowledge.',\n",
       "  u'08-755 80 80',\n",
       "  u'http://www.scanddev.se',\n",
       "  u'anna.torner@scanddev.se',\n",
       "  u'Sv\\xe4rdv\\xe4gen 3B\\n18233 Danderyd',\n",
       "  (u'Category', u'Service'),\n",
       "  (u'Founded', u'2012'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Number of employees', u'10')],\n",
       " [u'http://www.swedishlifesciences.se/tataa-biocenter-ab',\n",
       "  u'TATAA Biocenter AB',\n",
       "  u'Real-time PCR services and products',\n",
       "  u'G\\xf6teborg',\n",
       "  u'Service',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/809/logo/343_logo_low.jpg?itok=Qiu8fgqn',\n",
       "  '',\n",
       "  (u'CEO', u'Mikael Kubista'),\n",
       "  u'TATAA Biocenter is Europe\\u2019s leading provider of gene expression profiling services, a prime organizer of hands-on training in quantitative real-time PCR (qPCR) and the most complete provider of qPCR products in Sweden. Our offer comprises the entire field of qPCR services, including commissioned services and research projects, hands-on training and highest quality products. Our services include sample extraction, gene expression analysis, SNP typing, qPCR data analysis and much more. We are ISO 17025 certified.',\n",
       "  u'031-7615700',\n",
       "  u'http://www.tataa.com',\n",
       "  u'info@tataa.com',\n",
       "  u'http://www.facebook.com/pages/TATAA-Biocenter/224624947578008',\n",
       "  u'Odinsgatan 28\\n41103 G\\xf6teborg',\n",
       "  (u'Category', u'Service'),\n",
       "  (u'Founded', u'2003'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Revenue', u'11.5 MSEK in Sweden'),\n",
       "  (u'Number of employees', u'18'),\n",
       "  (u'Chairman', u'Mikael Kubista'),\n",
       "  (u'Principal owners', u'Founders')],\n",
       " [u'http://www.swedishlifesciences.se/tfs-international-ab',\n",
       "  u'TFS International AB',\n",
       "  u'Clinical Contract Research Organisation',\n",
       "  u'Lund',\n",
       "  u'CROs',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/676/logo/tfs_corp_trust.jpg?itok=7a2EO2hP',\n",
       "  '',\n",
       "  (u'Business Unit Director', u'Jan Hellqvist'),\n",
       "  u'TFS International is the largest global independent clinical Contract Research Organization (CRO). Founded in 1996 in Sweden, TFS currently operates in over 20 countries throughout Europe, USA, Canada and Japan and employs more than 650 professionals. TFS core therapeutic areas of expertise are Oncology, Immunology, Dermatology, Ophthalmology, CNS, Cardiology and Endocrinology. Through two business areas, TFS DevelopTM and TFS PeopleTM, TFS provides services worldwide as end-to-end solutions or tactical functional services. Detailed information about TFS, its business offerings, global locations and recent press releases can be obtained through www.tfscro.com.',\n",
       "  u'+46 (0)46 280 18 00',\n",
       "  u'http://www.tfscro.com',\n",
       "  u'tfs.international@tfscro.com',\n",
       "  u'Box 165\\nSE-22100 Lund',\n",
       "  (u'Category', u'Contract Research Organisations'),\n",
       "  (u'Founded', u'1996'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Revenue', u'50 MEUR Worldwide'),\n",
       "  (u'Number of employees', u'650'),\n",
       "  (u'Chairman', u'Ulf Ros\\xe9n'),\n",
       "  (u'Principal owners', u'Private ownership')],\n",
       " [u'http://www.swedishlifesciences.se/umecrine-mood-ab',\n",
       "  u'Umecrine Mood AB',\n",
       "  u'Relief for severe premenstrual symptoms',\n",
       "  u'Solna',\n",
       "  u'Biotech',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/947/logo/umecrine-mood-web.jpg?itok=QrAi8aZR',\n",
       "  '',\n",
       "  (u'CEO', u'Karin Ekberg'),\n",
       "  u\"Umecrine Mood AB is developing a novel treatment the symptoms associated with Premenstrual Dysphoric Disorder (PMDD), a condition affecting about 5% of all women in fertile age. This is a condition that have great impact on the quality of life for the patients and her family. \\r\\nIn addition to a few lead compounds in preclincal stage, the company's selected candidate drug is the first in class of so called GAMSA (GABA-A receptor modulating steroid antagonists). \\r\\nThe discovery of these compounds are based on research from Ume\\xe5 university. The company is part of the Karolinska Development company portfolio\",\n",
       "  u'08-52484482',\n",
       "  u'http://www.umecrine.se',\n",
       "  u'karin.ekberg@umecrine.se',\n",
       "  u'Fogdevreten 2\\nKarolinska Institutet Science Park\\n17165 Solna',\n",
       "  (u'Category', u'Biotech'),\n",
       "  (u'Looking for capital', u'Yes'),\n",
       "  (u'Founded', u'2006'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Revenue', u'0 MSEK in Sweden'),\n",
       "  (u'Number of employees', u'2'),\n",
       "  (u'Chairman', u'Ola Flink'),\n",
       "  (u'Principal owners', u'Umecrine AB, Kurma Biofund')],\n",
       " [u'http://www.swedishlifesciences.se/vironova',\n",
       "  u'Vironova',\n",
       "  u'Virus and nanoparticle innovator',\n",
       "  u'Stockholm',\n",
       "  u'CROs',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/1027/logo/3434_logo_low.jpg?itok=rrqVsbEv',\n",
       "  '',\n",
       "  (u'CEO', u'Mohammed Homman'),\n",
       "  u'Vironova AB (publ) is a privately held Swedish biotech company dedicated to the development of novel antiviral therapeutics and virus diagnostics products to combat and prevent the spread of viral diseases. Based on proprietary technology to analyze viruses and nanoparticles by electron microscopy, Vironova also provides services for the bio-nanotech industry that is able to cut time and costs in development and production of nanoparticle based therapeutics.\\r\\n\\r\\nThe subsidiary Vironova Biosafety offers the expertise and know-how in ensuring virus safety in the manufacture of biopharmaceuticals.',\n",
       "  u'08-7026790',\n",
       "  u'http://www.vironova.com',\n",
       "  u'info@vironova.com',\n",
       "  u'G\\xe4vlegatan 22\\n11330 Stockholm',\n",
       "  (u'Category', u'Contract Research Organisations'),\n",
       "  (u'Looking for capital', u'Yes'),\n",
       "  (u'Founded', u'2005'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Revenue', u'7 MSEK Worldwide'),\n",
       "  (u'Number of employees', u'27'),\n",
       "  (u'Chairman', u'Anders Milton'),\n",
       "  (u'Principal owners', u'M.Homman AB')],\n",
       " [u'http://www.swedishlifesciences.se/vwr-international-ab',\n",
       "  u'VWR International AB',\n",
       "  u'All you need for your laboratory',\n",
       "  u'Stockholm',\n",
       "  u'Suppliers (Distributors)',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/754/logo/vwr_weenablescience_cmyk.jpg?itok=j1AdAOhC',\n",
       "  '',\n",
       "  (u'CEO', u'Thomas Best'),\n",
       "  u'VWR (NASDAQ: VWR), headquartered in Radnor, Pennsylvania, is a global laboratory supply and distribution company with worldwide sales in excess of  $4.1 billion in 2013. VWR enables the advancement of the world\\xb4s most critical research through the distribution of a highly diversified product line to most of the world\\xb4s top pharmaceutical and biotech companies, as well as industrial, educational and governmental organizations. VWR has over 7000 associates around the world working to streamline the way researchers across North America, Europe, and Asia stock and maintain their labs.',\n",
       "  u'08-621 34 00',\n",
       "  u'http://se.vwr.com',\n",
       "  u'kundservice@se.vwr.com',\n",
       "  u'(Fagerstagatan 18 A)\\nFagerstagatan 18A\\n163 94 Stockholm',\n",
       "  (u'Category', u'Suppliers (Distributors)'),\n",
       "  (u'Founded', u'1906'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Revenue', u'610 MSEK in Sweden'),\n",
       "  (u'Number of employees', u'140'),\n",
       "  (u'Chairman', u'Henrik Russmann'),\n",
       "  (u'Principal owners', u'VWR Funding Inc.')],\n",
       " [u'http://www.swedishlifesciences.se/world-courier-sweden-ab',\n",
       "  u'World Courier (Sweden) AB',\n",
       "  u'Temperature Controlled Logistics',\n",
       "  u'ARLANDASTAD',\n",
       "  u'Service',\n",
       "  u'http://www.swedishlifesciences.se/sites/default/files/styles/logo_table_index/public/company_profiles/885/logo/world_courier_cmyk.png?itok=TSGYdrg0',\n",
       "  '',\n",
       "  (u'Business Unit Director', u'Mattias Mineur'),\n",
       "  u'Trust. It\\u2019s why more leading pharmaceutical companies rely on World Courier than any other specialty logistics company in the world. Companies trust us to transport their time- and temperature-sensitive products because they value the peace of mind that comes with our unsurpassed knowledge, global reach and flawless supply chain execution. No other specialty logistics company has the experienced personnel, global offices and in-market expertise required to ensure the optimal handling, transport and delivery of vital healthcare products. When trust is absolutely essential, there\\u2019s only one choice: World Courier',\n",
       "  u'08-59441480',\n",
       "  u'http://www.worldcourier.com',\n",
       "  u'ops@worldcourier.se',\n",
       "  u'https://twitter.com/Worldcourier',\n",
       "  u'Box 516\\nS\\xf6derbyv\\xe4gen 1A\\n19525 ARLANDASTAD',\n",
       "  (u'Category', u'Service'),\n",
       "  (u'Founded', u'1969'),\n",
       "  (u'Public company', u'No'),\n",
       "  (u'Number of employees', u'2500')]]"
      ]
     },
     "execution_count": 178,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "companies_full"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 179,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "path = '../data/dad_data.csv'\n",
    "with open(path, 'wb') as f:\n",
    "    w = csv.writer(f)\n",
    "    w.writerow(['URL', 'NAME', 'MOTTO', 'CITY', 'CATEGORY', 'LOGO_LINK', 'COMPANY_WEBSITE', 'OTHER_DATA'])\n",
    "    w.writerows([unicode(c_).encode(\"utf-8\") for c_ in c] for c in companies_full)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "url = 'http://www.biotechumea.se/'\n",
    "ext = 'pharmaceuticals-and-diagnostics'\n",
    "soup = BeautifulSoup(requests.get(url+ext).text, \"html.parser\")\n",
    "data = soup.find_all('div', class_ = 'item-list company-list')[1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "comp_list = [[l.text, url+l.a['href']] for l in data.find_all('li')]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 138,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "http://www.biotechumea.se/essum \n",
      "http://www.biotechumea.se/helicure \n",
      "http://www.biotechumea.se/inrobiomedtek \n",
      "http://www.biotechumea.se/it-instrumentteknik \n",
      "http://www.biotechumea.se/pelagia-miljokonsult \n",
      "http://www.biotechumea.se/techtum-lab \n"
     ]
    }
   ],
   "source": [
    "comp_list_full = []\n",
    "for c in comp_list:\n",
    "    try:\n",
    "        soup = BeautifulSoup(requests.get(c[1]).text, \"html.parser\")\n",
    "        data = soup.find('div', class_ = 'CS_article')\n",
    "        a = [d.text for d in data.find_all(['h1', 'div'], recursive=False)[:-1]]+[d.get_text(strip=True) for d in data.find_all('div', recursive=False)[-1].find_all(['p', 'div'], recursive=False)]\n",
    "        comp_list_full = comp_list_full+[c+a]\n",
    "    except:\n",
    "        comp_list_full = comp_list_full+[c]\n",
    "        print c[1] "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 139,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "path = '../data/dad_data_2.csv'\n",
    "with open(path, 'wb') as f:\n",
    "    w = csv.writer(f)\n",
    "    w.writerow(['NAME', 'LINK', 'DESCRIPTION', 'DESCRIPTION2', 'CONTACT', 'CONTACT_DETAILS'])\n",
    "    w.writerows([unicode(c_).encode(\"utf-8\") for c_ in c] for c in comp_list_full)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 2",
   "language": "python",
   "name": "python2"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.10"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 0
}
